Thiogenesis Therapeutics, Corp. — Form D
Thiogenesis Therapeutics, Corp. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-08. The offering totals $125K, of which $125K was reported sold. Industry: Other.
Offering
- Filed: 2025-08-08
- Form: D
- Accession: 0001062993-25-013902
- Industry: Other
- Exemptions: 06b
- Total offering: $125K
- Amount sold: $125K
- Date of first sale: 2025-07-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-554081
Issuer
- Name: Thiogenesis Therapeutics, Corp.
- CIK: 0001877778
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2018
- Address: 4 KING STREET WEST, SUITE 401, TORONTO, A6, M5H 1B6
- Phone: (888) 223-9165
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| W. Hogan G Mullally | Director | Torontoonta, A6 |
| Brook G Riggins | Director | Toronto, A6 |
| Patrice G Rioux | Director | Toronto, A6 |
| Christopher G Starr | Director | Toronto, A6 |
| Kim G Tsuchimoto | Director | Toronto, A6 |
| Brook G Riggins | Executive Officer | Toronto, A6 |
| Patrice G Rioux | Executive Officer | Toronto, A6 |
| Hogan W Mullally | Director | Toronto, A6 |
| Kim W Tsuchimoto | Director | Toronto, A6 |
| Patrice Rioux | Director | Toronto, A6 |
| Patrice Rioux | Executive Officer | Toronto, A6 |
| Patrice Rioux | Related Person | Toronto, A6 |
| Brook Riggins | Director | Toronto, A6 |
| Brook Riggins | Executive Officer | Toronto, A6 |
| Christopher W Starr | Director | Toronto, A6 |
| Christopher Starr | Related Person | Toronto, A6 |
| Neil A Johnson | Director | Toronto, A6 |
| Neil A Johnson | Executive Officer | Toronto, A6 |
| W. Hogan A Mullally | Director | Toronto, A6 |
| Brook G. Riggins | Related Person | Toronto, A6 |
| W. Hogan Mullally | Related Person | Toronto, A6 |
| Kim Tsuchimoto | Related Person | Toronto, A6 |
Other filings by this issuer (4)
More